Prostate Cancer: Are We Over-Diagnosing-or Under-Thinking?

European Urology

Volumn 53, Issue 1, 2008, Pages 10-12

  Jones, J Stephen ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

CANCER DIAGNOSIS; CANCER SCREENING; CRYOTHERAPY; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC VALUE; EDITORIAL; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; MALE; PATIENT COUNSELING; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; TUMOR BIOPSY;

BIOPSY; CLINICAL COMPETENCE; DIAGNOSTIC ERRORS; HUMANS; MALE; MASS SCREENING; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

EID: 36448995766     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2007.08.045     Document Type: Editorial

References (20)

1. Schmidt J.D., Mettlin C.J., Natarajan N., et al. Trends in patterns of care for prostatic cancer, 1974-1983: results of surveys by the American College of Surgeons. J Urol 136 (1986) 416-421
2. Ablin R.J., Bronson P., Soanes W.A., and Witebsky E. Tissue- and species-specific antigens of normal human prostatic tissue. J Immunol 104 (1970) 1329-1339
3. Hodge K.K., McNeal J.E., Terris M.K., et al. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 142 (1989) 71-75
4. Applewhite J.C., Matagla B.R., and McCullough D. Results of the 5 region prostate biopsy method: the repeat biopsy population. J Urol 168 (2002) 500-503
5. Epstein J.I., Walsh P.C., and Carter H.B. Importance of posterolateral needle biopsies in the detection of prostate cancer. Urology 57 (2001) 1112-1116
6. Brand T.C., and Thompson I.M. Prostate cancer screening: navigating the controversy. In: Jones J.S. (Ed). Prostate biopsy: indications, techniques, and complications (2007), Humana Press, Totowa, NJ
7. Bryant R.J., and Hamdy F.C. Screening for prostate cancer: an update. Eur Urol 53 (2008) 37-44
8. Thompson I.M., Pauler D.K., Goodman P.J., et al. Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per millilitre. N Engl J Med 350 (2004) 2239-2246
9. Hong Y.M., Lai F.C., Chon C.H., McNeal J.E., and Presti Jr. J.C. Impact of prior biopsy scheme on pathologic features of cancers detected on repeat biopsies. Urol Oncol 22 (2004) 7-10
10. Graif T., Loeb S., Roehl K.A., et al. Under diagnosis and over diagnosis of prostate cancer. J Urol 178 (2007) 88-92
11. Carroll P.R. Early stage prostate cancer-do we have a problem with over-detection, overtreatment or both?. J Urol 173 (2005) 1061-1062
12. Meng M.V., Elkin E.P., Harlan S.R., Mehta S.S., Lubeck D.P., and Carroll P.R. Predictors of treatment after initial surveillance in men with prostate cancer: results from CaPSURE. J Urol 170 (2003) 2279-2283
13. Holmberg L., Bill-Axelson A., Helgesen F., et al., Scandinavian Prostatic Cancer Group Study Number 4. A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer. N Engl J Med 347 (2002) 781-789
14. Hall G.S., Kramer C.E., and Epstein J.I. Evaluation of radical prostatectomy specimens. A comparative analysis of sampling methods. Am J Surg Pathol 16 (1992) 315-324 (This large study identifies the likelihood of having multifocal tumors, and suggests that features of the index tumor primarily determine biological behavior.)
15. Villers A., McNeal J.E., Freiha F.S., et al. Multiple cancers in the prostate. Morphologic features of clinically recognized vs. incidental tumors. Cancer 70 (1992) 2312-2318
16. Rukstalis D.B., Goldknoph J.L., Crowley E.M., et al. Prostate cryoablation: a scientific rationale for future modifications. Urology 60 2 suppl 1 (2002) 19-25
17. Bahn D.K., Silverman P., Lee Sr. F., Badalament R., Bahn E.D., and Rewcastle J.C. Focal prostate cryoablation: initial results show cancer control and potency preservation. J Endourol 20 (2006) 688-692
18. Poissonnier L., Chapelon J.-Y., Rouvière O., et al. Control of prostate cancer by transrectal HIFU in 227 patients. Eur Urol 51 (2007) 381-387
19. Sakr W.A., et al. Epidemiology of high grade prostatic intraepithelial neoplasia. Pathol Res Pract 191 (1995) 838-841
20. Ries L.A.G., Eisner M.P., Kosary C.L., et al. SEER Cancer Statistics Review, 1975-2000 (2003), National Cancer Institute, Bethesda, MD. http://seer.cancer.gov./csr/1975_2000